Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

SNY

Sanofi ADR

May 15 • 03:02PM ET

48.85

Dollar change -0.65
Percentage change -1.31	%

Healthcare • Drug Manufacturers - General • France • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	21.03	EPS (ttm)	2.32	Insider Own	0.02%	Shs Outstand	2.51B	Perf Week	-2.50%
Market Cap	122.40B	Forward P/E	10.36	EPS next Y	4.71	Insider Trans	0.00%	Shs Float	2.51B	Perf Month	6.66%
Income	5.84B	PEG	2.34	EPS next Q	0.84	Inst Own	10.07%	Short Float	0.22%	Perf Quarter	6.66%
Sales	46.56B	P/S	2.63	EPS this Y	-6.11%	Inst Trans	-1.58%	Short Ratio	2.75	Perf Half Y	7.32%
Book/sh	32.68	P/B	1.49	EPS next Y	14.33%	ROA	4.25%	Short Interest	5.44M	Perf Year	-10.43%
Cash/sh	3.84	P/C	12.72	EPS next 5Y	9.00%	ROE	7.22%	52W Range	42.63 - 55.72	Perf YTD	-1.77%
Dividend Est.	2.05 (4.20%)	P/FCF	13.25	EPS past 5Y	2.68%	ROI	5.86%	52W High	-12.33%	Beta	0.58
Dividend TTM	2.04 (4.17%)	Quick Ratio	0.87	Sales past 5Y	2.80%	Gross Margin	61.77%	52W Low	14.59%	ATR (14)	1.01
Dividend Ex-Date	May 09, 2024	Current Ratio	1.27	EPS Y/Y TTM	-33.10%	Oper. Margin	21.32%	RSI (14)	51.11	Volatility	1.23% 1.70%
Employees	87994	Debt/Eq	0.25	Sales Y/Y TTM	3.18%	Profit Margin	12.54%	Recom	1.62	Target Price	57.80
Option/Short	Yes / Yes	LT Debt/Eq	0.22	EPS Q/Q	-	Payout	63.38%	Rel Volume	2.26	Prev Close	49.50
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-13.36%	Earnings	Apr 25 BMO	Avg Volume	1.98M	Price	48.85
SMA20	0.59%	SMA50	1.51%	SMA200	-1.78%	Trades		Volume	3,837,068	Change	-1.31%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-23-24	Initiated	Morgan Stanley	Equal-Weight	$55
Jan-16-24	Resumed	UBS	Buy
Dec-05-23	Downgrade	JP Morgan	Overweight → Neutral
Oct-30-23	Downgrade	Stifel	Buy → Hold
Sep-06-23	Upgrade	Berenberg	Hold → Buy
Jul-14-23	Initiated	HSBC Securities	Buy
Apr-28-23	Downgrade	Deutsche Bank	Hold → Sell
Mar-27-23	Upgrade	Barclays	Equal Weight → Overweight
Dec-13-22	Resumed	Morgan Stanley	Overweight
Aug-12-22	Upgrade	Deutsche Bank	Sell → Hold
Aug-09-22	Downgrade	UBS	Buy → Neutral
May-23-22	Initiated	SVB Leerink	Outperform
Sep-27-21	Upgrade	SVB Leerink	Mkt Perform → Outperform
Jan-15-21	Initiated	Deutsche Bank	Sell
Sep-29-20	Initiated	Berenberg	Hold
Mar-17-20	Upgrade	Barclays	Underweight → Equal Weight
Mar-11-20	Upgrade	Goldman	Neutral → Buy
Feb-11-20	Initiated	SVB Leerink	Mkt Perform
Jan-06-20	Upgrade	JP Morgan	Neutral → Overweight
Sep-23-19	Upgrade	Guggenheim	Neutral → Buy

Show Previous Ratings

Today 06:48AM	3 Stocks Under $2 That Can Trade in Double Digits by 2025 (InvestorPlace)
06:32AM	Novavax Soars on Sanofi Deal: A Smart Buy or Post-Hype Correction? (FX Empire)
05:35AM	Novavax Stock Just Tripled. Is It Too Late to Buy? (Motley Fool)
May-14-24 10:24AM	3 Cheap Biotech Stocks to Buy Now: May 2024 (InvestorPlace)
07:01AM	Sanofi to make 1bn biomanufacturing investment in France (Pharmaceutical Technology)
06:47AM	Loading…
06:47AM	3 Meme Stocks That Are Likely to Crater in 2024 (InvestorPlace)
05:11AM	Does Soaring Novavax Stock Have Enough Fuel to Climb Higher? (Motley Fool)
03:01AM	Fulcrum Therapeutics Inc (FULC) Q1 2024 Earnings Call Transcript Highlights: Strategic ... (GuruFocus.com)
May-13-24 01:01PM	Barrow, Hanley, Mewhinney & Strauss Bolsters Portfolio with Strategic Additions in Q1 2024 (GuruFocus.com)
11:02AM	Sanofi strikes $1bn deal with Fulcrum for muscular dystrophy drug (Pharmaceutical Technology)
10:25AM	Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag (Zacks)
08:45AM	Fulcrum Therapeutics, Sanofi Sign Licensing Deal for Facioscapulohumeral Muscular Dystrophy Treatment (MT Newswires)
08:36AM	Update: Sanofi to Invest $1.08 Billion Into Three French Drug Manufacturing Sites (MT Newswires)
08:32AM	Fulcrum Therapeutics Q1 2024 Earnings: Misses Analyst Net Income Projections Amid Strategic ... (GuruFocus.com)
07:47AM	Sanofi gambles $80M on Fulcrums muscular dystrophy drug (BioPharma Dive)
07:42AM	Loading…
07:42AM	Sanofi to Invest $1.08 Billion Into 3 French Drug Manufacturing Sites (MT Newswires)
07:30AM	France bags $16 billion investment boost from Microsoft, Pfizer and others as Macron goes on FDI charm offensive (Fortune)
07:23AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace)
07:11AM	Sanofi pays $80M to add Roche-rivaling Fulcrum drug to phase 3 rare disease pipeline (FierceBiotech.com)
07:00AM	Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2024 (GlobeNewswire)
06:00AM	Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Development and Commercialization of Losmapimod in Facioscapulohumeral Muscular Dystrophy (GlobeNewswire)
04:41AM	Regeneron Pharmaceuticals, Sanofi Say FDA Accepts Dupixent Supplemental Application for Priority Review (MT Newswires)
03:03AM	Novavax Inc (NVAX) (Q1 2024) Earnings Call Transcript Highlights: Strategic Partnerships and ... (GuruFocus.com)
02:58AM	PRESS DIGEST- Wall Street Journal - May 13 (Reuters)
02:41AM	Sanofi to Spend $1.08 Billion to Boost Drug Production in France (The Wall Street Journal)
01:00AM	Press Release: Sanofi adds over 1 billion for biomanufacturing to 2.5 billion already committed in major projects in France to support health sovereignty (GlobeNewswire)
01:00AM	Dupixent (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP) (GlobeNewswire)
May-12-24 10:10PM	Analyst Report: Sanofi (Morningstar Research)
May-10-24 05:56PM	Fed rates, Tesla Supercharger backpedal, Novavax's 'new chapter': Market Domination (Yahoo Finance Video)
04:26PM	Sanofi vaccine deal kicks off Novavax's 'new chapter': Analyst (Yahoo Finance Video)
04:16PM	Loading…
04:16PM	Novavaxs 99% Surge Gives Rib-Crunching Squeeze to Shorts (Bloomberg)
04:08PM	Novavax stock doubles after Sanofi deal marks 'new chapter' for company (Yahoo Finance)
01:53PM	Sector Update: Health Care Stocks Advance Friday Afternoon (MT Newswires)
01:46PM	Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with Strategic Partnerships and Cost ... (GuruFocus.com)
01:44PM	Top MIdday Gainers (MT Newswires)
01:31PM	Sector Update: Health Care (MT Newswires)
01:24PM	Novavax CEO on Sanofi deal: 'This is a new chapter in the history of our company' (Yahoo Finance)
01:08PM	Why Novavax Stock More Than Doubled Today (Motley Fool)
01:02PM	NVAX Stock Alert: Novavax Just Hit a New 52-Week High (InvestorPlace)
12:28PM	Novavax Sheds Going Concern Warning as NVAX Stock Pops on Sanofi Licensing Deal (InvestorPlace)
12:06PM	Top Midday Stories: Biden to Reportedly Quadruple Chinese EV Tariffs; Novavax Shares Soar on Sanofi Deal News; Protesters Try to Break Into Tesla's Plant in Germany; FDA Pushes Back Approval of Moderna Vaccine (MT Newswires)
11:43AM	Biotech Rockets 125% On Sanofi Covid Vaccine Agreement (Investor's Business Daily)
11:31AM	Novavax-Sanofi vaccine deal, Yelp and Sweetgreen earnings: Morning Brief (Yahoo Finance Video)
11:25AM	Novavax Stock Price More Than Doubles After COVID-19 Vaccine Licensing Deal With Sanofi (MT Newswires)
10:36AM	Novavax Stock Doubles on $1.2B Sanofi Deal for COVID-19, Flu Vaccines (Investopedia)
10:34AM	Novavax Stock More Than Doubles After Sanofi Vaccine-Licensing Deal (The Wall Street Journal)
10:20AM	Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi (Quartz)
10:14AM	Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal (Bloomberg)
10:06AM	Update: Novavax Unveils COVID-19 Vaccine Licensing Deal With Sanofi; Shares Soar (MT Newswires)
10:06AM	Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases Doubts About Its Going Concern (Benzinga)
10:05AM	Novavax shares skyrocket on $1.2 billion Sanofi vaccine deal (Yahoo Finance Video)
09:53AM	Novavax Stock Surges 140% on $1.4 Billion Deal With Sanofi (Barrons.com)
09:50AM	These Stocks Are Moving the Most Today (Barrons.com)
09:17AM	Stock markets, China tariffs, Novavax and Sanofi: 3 Things (Yahoo Finance Video)
07:47AM	US STOCKS-Futures rise ahead of data, speeches from Fed officials (Reuters)
07:30AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
06:30AM	3 Biotech Stocks to Sell in May Before They Crash & Burn (InvestorPlace)
05:45AM	Maze lands new partner for Pompe drug, after Sanofi pact came apart (BioPharma Dive)
05:14AM	Novavax Unveils Deal With Sanofi to Co-commercialize COVID-19 Vaccine, Develop Novel Medication (MT Newswires)
05:03AM	After FTC stalled Sanofi deal, Shionogi secures Maze's Pompe disease drug for $150M (FierceBiotech.com)
02:19AM	UPDATE 3-Novavax signs COVID-19 license deal with Sanofi, revokes 'going concern' warning (Reuters)
02:15AM	Novavax Reports First Quarter 2024 Financial Results and Operational Highlights (PR Newswire)
02:09AM	France's Sanofi in COVID-19 vaccine deal with Novavax - statement (Reuters)
02:00AM	Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines (GlobeNewswire)
02:00AM	Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines (PR Newswire)
12:34AM	Q1 2024 Royalty Pharma PLC Earnings Call (Thomson Reuters StreetEvents)
May-09-24 10:44AM	Royalty Pharma to Acquire Frexalimab Royalties, Milestones for $525 Million in Cash (MT Newswires)
07:38AM	Royalty Pharma pays startup $525M for stake in Sanofi MS drug (BioPharma Dive)
06:30AM	The 3 Most Undervalued Pharma Stocks to Buy in May 2024 (InvestorPlace)
May-08-24 03:36PM	DoubleVerify Holdings, Inc. (NYSE:DV) Q1 2024 Earnings Call Transcript (Insider Monkey)
01:22PM	Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript (Insider Monkey)
01:12PM	Dr. Reddy's Laboratories Limited (NYSE:RDY) Q4 2024 Earnings Call Transcript (Insider Monkey)
10:33AM	Sanofi's New Cancer Drug Could Help Deliver a Big Payday (Motley Fool)
09:48AM	Sanofi CSO Frank Nestle is leaving (FierceBiotech.com)
07:03AM	Sanofi SA's Dividend Analysis (GuruFocus.com)
May-06-24 02:06PM	How the Medical Industry Could Produce the Biggest AI Stock Winners (InvestorPlace)
02:01PM	Update: Market Chatter: Bank of America, BNP Set to Win Lead Roles on Sanofi's Consumer-Healthcare Spin Off (MT Newswires)
11:59AM	BofA, BNP Poised to Win Lead Roles on $20 Billion Sanofi Spinoff (Bloomberg)
10:59AM	Bank of America, BNP Set to Win Lead Roles on Sanofi's $20 Billion Consumer Healthcare Spin Off, Bloomberg Reports (MT Newswires)
May-03-24 12:23PM	Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q1 2024 Earnings Call Transcript (Insider Monkey)
10:15AM	Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-02-24 11:59PM	Q1 2024 Kymera Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
07:15AM	3 Biotech Stocks to Buy and Hold Through 2030 and Beyond (Motley Fool)
01:00AM	Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations (GlobeNewswire)
Apr-30-24 01:22PM	Sanofi (NASDAQ:SNY) Q1 2024 Earnings Call Transcript (Insider Monkey)
12:00PM	Press Release: Annual General Meeting of April 30, 2024 (GlobeNewswire)
Apr-29-24 02:23AM	Analyst Report: Sanofi (Morningstar Research)
Apr-26-24 05:52AM	Analyst Report: Sanofi (Morningstar Research)
Apr-25-24 04:01PM	AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge (Investor's Business Daily) +5.90%
01:45PM	Sanofi (SNY) Q1 2024 Earnings Call Transcript (Motley Fool)
01:30PM	CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript (Insider Monkey)
11:34AM	20 Fastest Growing Health Tech Companies in the World (Insider Monkey)
11:19AM	Sanofi (SNY) Q1 Earnings In Line, Sales Miss Estimates, Stock Up (Zacks)
09:01AM	Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday (MT Newswires)
08:50AM	Sanofi CEO Paul Hudson on Q1 results: Hope to gather even more momentum later this year (CNBC TV)
08:15AM	REFILE-AbbVie's Rinvoq shows superiority to Regeneron's Dupixent in study (Reuters)
08:11AM	Sanofi Q1 Profit Weak, But Sales Rise; Backs FY24 View; Stock Up (RTT News)
07:53AM	SNY Stock Earnings: Sanofi Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
07:52AM	Sanofi: Q1 Earnings Snapshot (Associated Press Finance)
07:31AM	AstraZeneca, Sanofi Jump On First-Quarter Earnings; Bristol Myers Lags (Investor's Business Daily)

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SNY

Sanofi ADR

Upgrade your FINVIZ experience